Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07550413
PHASE2

Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section

Sponsor: Pak Emirates Military Hospital

View on ClinicalTrials.gov

Summary

To determine the effectiveness of prophylactic intravenous calcium chloride administered after cord clamping in reducing postpartum blood loss during intrapartum cesarean section.

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

182

Start Date

2026-05

Completion Date

2026-12

Last Updated

2026-04-24

Healthy Volunteers

Yes

Interventions

DRUG

Calcium Chloride

Group A will receive 1 g of intravenous calcium chloride diluted in 100 mL of normal saline, administered over 10 minutes beginning one minute after cord clamping, in addition to standard oxytocin therapy (10 IU intravenous bolus followed by 20 IU infusion).

OTHER

Placebo

Group B will receive standard care with oxytocin alone.

Locations (1)

Pak Emirates Military Hospital

Rawalpindi, Punjab Province, Pakistan